Introduction to Treating Oligometastatic Crpc With Radiation To Delay Hormonal Therapy
Welcome to our comprehensive guide on Treating Oligometastatic Crpc With Radiation To Delay Hormonal Therapy. Evidence from the recent SPARTAN and PROSPER trials indicate the use of apalutamide and enzalutamide in M0 ...
Treating Oligometastatic Crpc With Radiation To Delay Hormonal Therapy Comprehensive Overview
Dose-Escalated Eric Bent, MD, PhD, Memorial Sloan-Kettering Cancer Center, Cambridge, MA comments on metastasis directed Chad Tang, MD, University of Texas MD Anderson Cancer Center, Houston, TX, explains the rationale, study design, and results ...
Giulio Francolini, MD, University of Florence, Florence, Italy outlines the ARTO trial (NCT03449719), a randomized phase II trial ...
Summary & Highlights for Treating Oligometastatic Crpc With Radiation To Delay Hormonal Therapy
- Sophia Kamran, MD, Massachusetts General Hospital, Boston, MA, describes the future role of
- Eric Bent, MD, PhD, Memorial Sloan-Kettering Cancer Center, Cambridge, MA, discusses results from cohorts B2 and B2 ...
- ... algo metastatic recurrences and do what we call metastasis directed
- A regional roundtable discussion, moderated by L. Crain Garrot, MD, Georgia Cancer Specialists, focused on the diagnostic and ...
- Radiologist Dr. Julian Hong plains how stereotactic body
In summary, understanding Treating Oligometastatic Crpc With Radiation To Delay Hormonal Therapy gives us a better perspective.